Delivery Order SPE2DB22D1002-SPE2DB25FKXV6

Award Date 2/6/25
Potential Completion Date 2/7/25
Potential Value $5.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,437.90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 36,000 unit capsules of the product "CREON DR", a medical commodity. The contract is a Firm Fixed Price Delivery Order with a completion date of January 28, 2025. The award is associated with a larger Indefinite Delivery Contract (IDC) held by...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor in the United States. The $25,252.08 firm-fixed-price delivery order is for the supply of 36,000 units of the pharmaceutical product CREON DR in 100 count capsule bottles. The award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical,...
This federal contract award, valued at $1,758.30, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a large pharmaceutical distributor. The contract is for the delivery of 12,000 unit capsules of the drug CREON DR, a prescription medication. This award is a delivery order under an Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which has a ceiling value of up to $999,999,999 and provides a wide range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 36,000 units of the drug product CREON DR 250S capsules. The award, valued at $2,614.87, is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to $999,999,999.00, serves as the primary vehicle for...
This federal contract award, valued at $13,259.62, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 36,000 unit capsules of the drug CREON DR, a medication used to treat various medical conditions. The contract has a firm fixed price and is a delivery order with a completion date of November 14, 2024. This award is part of a larger Indefinite Delivery Contract...
This federal contract award is a delivery order valued at $2,101.83 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The contract is for the supply of 36,000 units of CREON DR 100s capsules, a specialty pharmaceutical product, with a completion date of February 13, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of CREON DR 36,000 UNIT CAPSULE UU 100S. The contract is a Delivery Order valued at $2,985.97 with a Firm Fixed Price pricing type. The ultimate completion date for the contract is June 4, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 between Amerisourcebergen and DLA Troop...
This federal contract award, valued at $2,474.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division. The contract is for the delivery of 36,000 units of the pharmaceutical product CREON DR 36,000 UNIT CAPSULE in 100-count bottles. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which is valued up to $999,999,999 and runs through December 2025. This IDC enables the DLA to...
This federal contract award is for the delivery of 36,000 units of the pharmaceutical product CREON DR 36,000 UNIT CAPSULE UU 100S to the Defense Logistics Agency (DLA). The $7,142.00 firm fixed-price contract was awarded on June 14, 2024 to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, with a completion date of June 17, 2024. This is a delivery order issued under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,471.43 firm fixed-price delivery order is for 36,000 units of a medical product described as "CREON DR 36,000 UNIT CAPSULE UU 100S." This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running through...
  • SPE2DB22D1002
    Indefinite Delivery Contract
  • SPE2DB22D1002-SPE2DB25FKXV6
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp for the delivery of 36,000 units of the pharmaceutical product CREON DR 100S capsules. The delivery order, valued at $5,643.76, has a firm fixed price and an ultimate completion date of February 7, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award did not have a set-aside designation, indicating open competition.

Generated 5/8/25, 9:42 AM